Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02479139 · ClinicalTrials.gov registry record · Phase 2
Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis
A Phase 2 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 2
- Development phase
- 145
- Enrollment target
NCT02479139 is a Phase 2 study that has completed, run by Allergan. The registered enrollment target is 145 participants.
The verdict
NCT02479139, a Phase 2 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 145 participants
- Enrollment target
Study Summary
The purpose of this study is to establish the therapeutic range of ANT-1207 in the treatment of primary axillary hyperhidrosis.
Interventions
- BIOLOGICAL Vehicle
- BIOLOGICAL ANT-1207
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2015-06-03 |
| Est. Completion | 2016-02-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02479139
The ClinicalTrials.gov registry entry for NCT02479139 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT02479139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02479139 about?
NCT02479139 is a clinical study titled "Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis". The purpose of this study is to establish the therapeutic range of ANT-1207 in the treatment of primary axillary hyperhidrosis.
What is the current status of trial NCT02479139?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 145 participants. The study started on 2015-06-03. Estimated completion is 2016-02-29.
What interventions are being tested in trial NCT02479139?
The interventions under investigation include: Vehicle (BIOLOGICAL), ANT-1207 (BIOLOGICAL).
Who is sponsoring clinical trial NCT02479139?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.